NCT03479411View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With Asthma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 9, 2018

Primary Completion Date

June 28, 2018

Study Completion Date

June 28, 2018

Conditions

Asthma

Interventions

DRUG

Itraconazole Powder

Itraconazole administered as a dry powder for inhalation (PUR1900)

DRUG

Itraconazole 200 mg

Sporanox® Oral Solution

Trial Locations (2)

Unknown

Medicines Evaluation Unit, Manchester

Quotient Sciences, Nottingham

All Listed Sponsors

lead

Pulmatrix Inc.

INDUSTRY

NCT03479411 - Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With Asthma | Biotech Hunter | Biotech Hunter